Champions Oncology, Inc. (FRA:2I3)

Germany · Delayed Price · Currency is EUR

5.60

0.00 (0.00%)

At close: Jan 9, 2026

Revenue by Product

Financials in millions USD. Fiscal year is May - April.

Millions USD. Fiscal year is May - Apr.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2003 - 2019
Period Ending	Apr '24 Apr 30, 2024	Apr '23 Apr 30, 2023	Apr '22 Apr 30, 2022	Apr '21 Apr 30, 2021	Apr '20 Apr 30, 2020	2003 - 2019
Pharmacology Services	48.59M	Log In	Log In	Log In	Log In	Upgrade
Pharmacology Services Growth	3.30%	Log In	Log In	Log In	Log In	Upgrade
Translational Oncology Solutions Data License	4.68M	Log In	Log In	Log In	Log In	Upgrade
Other Translational Oncology Solutions	3.68M	Log In	Log In	Log In	Log In	Upgrade
Other Translational Oncology Solutions Growth	18.73%	Log In	Log In	Log In	Log In	Upgrade
Personalized Oncology Services	-	Log In	Log In	Log In	Log In	Upgrade
Personalized Oncology Services Growth	-	Log In	Log In	Log In	Log In	Upgrade

Revenue by Geography

Financials in millions USD. Fiscal year is May - April.

Millions USD. Fiscal year is May - Apr.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2003 - 2019
Period Ending	Apr '24 Apr 30, 2024	Apr '23 Apr 30, 2023	Apr '22 Apr 30, 2022	Apr '21 Apr 30, 2021	Apr '20 Apr 30, 2020	2003 - 2019
United States	56.94M	Log In	Log In	Log In	Log In	Upgrade
United States Growth	13.54%	Log In	Log In	Log In	Log In	Upgrade